Chronic Kidney Disease as a Coronary Artery Disease Risk Equivalent
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Chronic kidney disease (CKD) is associated with accelerated cardiovascular disease (CVD) risk and a higher CVD event rate. Substantial data from prospective cohort studies support the concept that dialysis patients as well as those with advanced stage (stages 3-5) CKD are associated with an increased risk for all-cause and cardiovascular mortality. The risk for coronary artery disease (CAD) increases exponentially with declining kidney function, i.e., stage 3 or higher CKD. Indeed, CVD accounts for more than 50 % of deaths in patients with CKD. CKD patients are more likely to die of CVD than to progress to end stage kidney disease. This increase in CV risk is commonly attributed to co-existence of numerous traditional and nontraditional risk factors for the development of CVD that frequently accompany reduced kidney function. Therefore, CKD itself is now considered an independent CVD risk factor and a coronary artery disease (CAD) equivalent for all-cause mortality. All patients at risk for CAD should be evaluated for kidney disease. Treatments used for management of established CAD might have similar benefits for patients with concomitant CKD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, the risk of patients developing cardiovascular and renal events increase as DM and CKD progresses, potentially reaching renal and cardiac endpoint events such as ESRD, heart failure, myocardial infarction (MI) and stroke [11–14].”
Citations
Cites
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369
Levey, A. S., Coresh, J., Balk, E., Kausz, A. T., Levin, A., Steffes, M. W., Hogg, R. J., Perrone, R. D., Lau, J., & Eknoyan, G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-2-200307150-00013 · Cited by 4,615
Sarnak, M. J., Levey, A. S., Schoolwerth, A. C., Coresh, J., Culleton, B., Hamm, L. L., McCullough, P. A., Kasiske, B. L., Kelepouris, E., Klag, M. J., et al. (2003) · Circulation · doi:10.1161/01.cir.0000095676.90936.80 · Cited by 3,768
Baigent, C., Landray, M. J., Reith, C., Emberson, J., Wheeler, D. C., Tomson, C., Wanner, C., Krane, V., Cass, A., Craig, J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60739-3 · Cited by 2,479
Accelerated Atherosclerosis in Prolonged Maintenance Hemodialysis
Lindner, A., Charra, B., Sherrard, D. J., & Scribner, B. H. (1974) · New England Journal of Medicine · doi:10.1056/nejm197403282901301 · Cited by 1,776
Arterial Calcifications, Arterial Stiffness, and Cardiovascular Risk in End-Stage Renal Disease
Blacher, J., Guerin, A. P., Pannier, B., Marchais, S. J., & London, G. M. (2001) · Hypertension · doi:10.1161/hy1001.096358 · Cited by 1,417
Fox, C. S., Matsushita, K., Woodward, M., Bilo, H. J., Chalmers, J., Heerspink, H. J. L., Lee, B. J., Perkins, R. M., Rossing, P., Sairenchi, T., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61350-6 · Cited by 1,401
Fried, L. P. (1998) · JAMA · doi:10.1001/jama.279.8.585 · Cited by 1,107 · cited 1×
“5 mg/dl had a 70 % increase in risk for all-cause mortality after a 5 year follow-up [31].”
van der Velde, M., the Chronic Kidney Disease Prognosis Consortium, Matsushita, K., Coresh, J., Astor, B. C., Woodward, M., Levey, A. S., de Jong, P. E., & Gansevoort, R. T. (2011) · Kidney International · doi:10.1038/ki.2010.536 · Cited by 1,082
Cited by
Chronic Kidney Disease and Cardiovascular Disease: Is there Any Relationship?
Vallianou, N. G., Mitesh, S., Gkogkou, A., & Geladari, E. (2018) · Current Cardiology Reviews · doi:10.2174/1573403x14666180711124825 · Cited by 237
Coronary Artery Disease in Patients with Chronic Kidney Disease: A Clinical Update
Cai, Q., Mukku, V., & Ahmad, M. (2014) · Current Cardiology Reviews · doi:10.2174/1573403x10666140214122234 · Cited by 216
Heart failure in patients with kidney disease
Tuegel, C., & Bansal, N. (2017) · Heart · doi:10.1136/heartjnl-2016-310794 · Cited by 195
Staff, A. C., Redman, C. W. G., Williams, D., Leeson, P., Moe, K., Thilaganathan, B., Magnus, P., Steegers, E. A. P., Tsigas, E. Z., Ness, R. B., et al. (2016) · Hypertension · doi:10.1161/hypertensionaha.115.06357 · Cited by 184
Targeting Vascular Calcification in Chronic Kidney Disease
Nelson, A. J., Raggi, P., Wolf, M., Gold, A. M., Chertow, G. M., & Roe, M. T. (2020) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2020.02.002 · Cited by 161
Metadata
- Authors
- Briasoulis, A., & Bakris, G. L.
- Affiliations
- University of Chicago (US)
- Corresponding author
- Bakris, George L.
- ORCID
- Bakris, George L.
- Venue
- Current Cardiology Reports
- Published
- 2013-01-22
- Volume
- 15
- Issue
- 3
- Pages
- 340-340
- ISSN
- 1523-3782 (ISSN-L)
- 1534-3170
- OpenAlex
- W2008686408
- Cited by
- 152
- References
- 42
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 12 · 2023: 12 · 2022: 18 · 2021: 25 · 2020: 11 · 2019: 18 · 2018: 8 · 2017: 11 · 2016: 7 · 2015: 11 · 2014: 9 · 2013: 1
- FWCI
- 1.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Current Cardiology Reports (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Keywords
- chronic kidney disease, coronary artery disease, cardiovascular risk, cardiovascular mortality, all-cause mortality, dialysis, renal function decline, cardiovascular risk factors, end-stage renal disease, cardiovascular risk stratification
- MeSH terms
- Coronary Artery Disease, Humans, Risk Factors, Meta-Analysis as Topic, Renal Insufficiency, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chronic Kidney Disease as a Coronary Artery Disease Risk Equivalent. https://app.cochat.ai/papers/10.1007/s11886-012-0340-4
- The paper
- Briasoulis, A., & Bakris, G. L. (2013). Chronic Kidney Disease as a Coronary Artery Disease Risk Equivalent. Current Cardiology Reports. https://doi.org/10.1007/s11886-012-0340-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.